338 related articles for article (PubMed ID: 29679493)
21. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
22. The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.
Fernández-Ruiz J
Br J Pharmacol; 2019 May; 176(10):1370-1383. PubMed ID: 29856067
[TBL] [Abstract][Full Text] [Related]
23. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
Cavalli E; Mammana S; Nicoletti F; Bramanti P; Mazzon E
Int J Immunopathol Pharmacol; 2019; 33():2058738419838383. PubMed ID: 30900486
[TBL] [Abstract][Full Text] [Related]
24. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain.
Ruiz-Cantero MC; González-Cano R; Tejada MÁ; Santos-Caballero M; Perazzoli G; Nieto FR; Cobos EJ
Pharmacol Res; 2021 Jan; 163():105339. PubMed ID: 33276102
[TBL] [Abstract][Full Text] [Related]
25. Joint problems arising from lack of repair mechanisms: can cannabinoids help?
Malek N; Starowicz K
Br J Pharmacol; 2019 May; 176(10):1412-1420. PubMed ID: 29574720
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of cross-talk between thyroid hormone and peroxisome proliferator activated receptors: focus on the heart.
Hyyti OM; Portman MA
Cardiovasc Drugs Ther; 2006 Dec; 20(6):463-9. PubMed ID: 17171294
[TBL] [Abstract][Full Text] [Related]
27. How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders.
Kimura LF; Novaes LS; Picolo G; Munhoz CD; Cheung CW; Camarini R
Br J Pharmacol; 2022 Apr; 179(8):1640-1660. PubMed ID: 34076891
[TBL] [Abstract][Full Text] [Related]
28. Targeting AMPK for the Alleviation of Pathological Pain.
Asiedu MN; Dussor G; Price TJ
Exp Suppl; 2016; 107():257-285. PubMed ID: 27812984
[TBL] [Abstract][Full Text] [Related]
29. Roles of PPARs in NAFLD: potential therapeutic targets.
Tailleux A; Wouters K; Staels B
Biochim Biophys Acta; 2012 May; 1821(5):809-18. PubMed ID: 22056763
[TBL] [Abstract][Full Text] [Related]
30. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
31. Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain.
Gilron I; Ghasemlou N
Curr Opin Support Palliat Care; 2014 Dec; 8(4):429-36. PubMed ID: 25111256
[TBL] [Abstract][Full Text] [Related]
32. Citral: a monoterpene with prophylactic and therapeutic anti-nociceptive effects in experimental models of acute and chronic pain.
Nishijima CM; Ganev EG; Mazzardo-Martins L; Martins DF; Rocha LR; Santos AR; Hiruma-Lima CA
Eur J Pharmacol; 2014 Aug; 736():16-25. PubMed ID: 24792822
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumour actions of cannabinoids.
Hinz B; Ramer R
Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
35. Neuropathic low back pain in clinical practice.
Baron R; Binder A; Attal N; Casale R; Dickenson AH; Treede RD
Eur J Pain; 2016 Jul; 20(6):861-73. PubMed ID: 26935254
[TBL] [Abstract][Full Text] [Related]
36. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.
Hong F; Pan S; Guo Y; Xu P; Zhai Y
Molecules; 2019 Jul; 24(14):. PubMed ID: 31336903
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain.
Lee JYP; Saez NJ; Cristofori-Armstrong B; Anangi R; King GF; Smith MT; Rash LD
Br J Pharmacol; 2018 Jun; 175(12):2204-2218. PubMed ID: 29134638
[TBL] [Abstract][Full Text] [Related]
38. Systems Pathology of Neuropathic Pain and Fibromyalgia.
Ueda H
Biol Pharm Bull; 2019; 42(11):1773-1782. PubMed ID: 31685762
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of chronic pain by pain clinicians].
Hashizume K
Brain Nerve; 2012 Nov; 64(11):1315-22. PubMed ID: 23131743
[TBL] [Abstract][Full Text] [Related]
40. Animal models of chronic pain: Advances and challenges for clinical translation.
Burma NE; Leduc-Pessah H; Fan CY; Trang T
J Neurosci Res; 2017 Jun; 95(6):1242-1256. PubMed ID: 27376591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
